- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06475222
Facial Serum and Mask and Ready-to-drink Jelly From Thai Rice
Development and Effectiveness Evaluation of Facial Serum and Mask and Ready-to-drink Jelly From Thai Rice (Oryza Sativa L.)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study 1: 30 male and female participants, age 30-50 years will be randomly applied with facial serum producing from either 2% alpha albutin (standard facial serum) or Tubtim Chumphae rice extract on either right side or left side of their face daily for 12 weeks.
Study 2: 60 male and female participants, age 30-50 years will be randomly assigned into 2 groups including 1) control group (n = 30): participants will not receive any facial mask for 12 weeks and 2) treatment group (n = 30): participants will be applied with home-based program facial mask with Hom Pathum rice extract for 30 min/day, 2 days/week for 12 weeks.
Study 3: this study consists of 2 sub-studies. Study 3.1: 25 male and female participants, age 18-35 years will be randomly consumed with control jelly, jelly with Tubtim Chumphae rice, and jelly with Hom Pathum rice at 3.5 g/kg body weight. All participants will be measured for blood glucose levels before consumption and after consumption at 30, 60, 90, and 120 min. Study 3.2: 25 male and female participants, age 18-35 years will be randomly consumed with control jelly, jelly with Tubtim Chumphae rice, and jelly with Hom Pathum rice at 3.5 g/kg body weight. After each consumption, all participants will perform walking or running on treadmill at intensity of 80% maximal heart rate to measure maximal oxygen consumption.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Chonburi
-
Mueang, Chonburi, Thailand, 20131
- Piyapong Prasertsri
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male or female
- Age between 18 to 50 years
- Healthy
- Interested in facial serum with Thai rice extract or facial mask with Thai rice extract or jelly from with Thai rice
Exclusion Criteria:
- History of adverse effects from facial serum or mask application or jelly consumption
- Skin allergy
- Skin disorders
- Skin wounds
- History of allergy to Thai rice, particularly in Tubtim Chumpae and Hom Pathum
- History of allergy to facial serum or mask, i.e., serum or mask from rice
- History of allergy to gelatin
- Signs or symptoms of fever or infection
- Abnormal body mass index
- Regular smokers or alcohol drinkers (>2 times per week)
- Regular exerciser (>2 times per week or >150 min per week)
- Regular intake of dietary supplements, i.e., vitamins, antioxidants
- Hypertension, diabetes, cardiovascular disease, respiratory disease, endocrine disease, neuromuscular disease, musculoskeletal disease, liver disease, renal disease, immune disease, infectious disease, or cancer
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Study 1: Facial serum with alpha albutin
Participants will be randomly applied with home-based program of facial serum producing from 2% alpha albutin (standard facial serum) on either right side or left side of their face daily for 12 weeks.
|
Applying with facial serum with 2% alpha albutin as active comparator daily for 12 weeks.
|
|
Experimental: Study 1: Facial serum with Tubtim Chumpae rice extract
Participants will be randomly applied with home-based program of facial serum producing from Tubtim Chumpae rice extract on either right side or left side of their face daily for 12 weeks.
|
Applying with facial serum with Tubtim Chumpae rice extract as experimental intervention daily for 12 weeks.
|
|
Experimental: Study 2: Facial mask with Hom Pathum rice extract
Participants will receive home-based program of facial mask with Hom Pathum rice extract for 30 min/day, 2 days/week for 12 weeks.
|
Applying with facial mask with Hom Pathum rice extract as experimental intervention for 30 min/day, 2 days/week for 12 weeks.
|
|
Active Comparator: Study 3: Control jelly
Participants will consume with control jelly at 3.5 g/kg body weight.
Consumption will be taken at Burapha University.
|
Consumption with control jelly as active comparator at 3.5 g/kg body weight.
|
|
Experimental: Study 3: Jelly with Tubtim Chumpae rice
Participants will consume with Tubtim Chumpae rice jelly at 3.5 g/kg body weight.
Consumption will be taken at Burapha University.
|
Consumption with jelly with Tubtim Chumpae rice as experimental intervention at 3.5 g/kg body weight.
|
|
Experimental: Study 3: Jelly with Hom Pathum rice
Participants will consume with Hom Pathum rice jelly at 3.5 g/kg body weight.
Consumption will be taken at Burapha University.
|
Consumption with jelly with Hom Pathum rice as experimental intervention at 3.5 g/kg body weight.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Level of skin moisture
Time Frame: Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]
|
Studies 1 and 2 determine level of skin moisture in arbitrary unit (no unit) using Multiprobe Adapter System with Corneometer® CM 825 probe.
|
Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]
|
|
Level of skin elasticity
Time Frame: Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]
|
Studies 1 and 2 determine level of skin elasticity in arbitrary unit (no unit) using Multiprobe Adapter System with Cutometer® 580 probe.
|
Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]
|
|
Level of skin oiliness
Time Frame: Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]
|
Studies 1 and 2 determine level of skin oiliness in arbitrary unit (no unit) using Multiprobe Adapter System with Sebumeter® SM 815 probe.
|
Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]
|
|
Level of skin melanin
Time Frame: Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]
|
Studies 1 and 2 determine level of skin melanin in arbitrary unit (no unit) using Multiprobe Adapter System with Mexameter® MX18 probe.
|
Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]
|
|
Level of blood glucose
Time Frame: Before jelly consumption and after jelly consumption at 30, 60, 90, and 120 minutes
|
Study 3.1 determines level of blood glucose in mg/dL unit
|
Before jelly consumption and after jelly consumption at 30, 60, 90, and 120 minutes
|
|
Level of maximal oxygen consumption
Time Frame: After jelly consumption for 30 minutes
|
Study 3.2 determines level of maximal oxygen consumption in mL/kg/min unit by walking or running on treadmill at intensity of 80% maximal heart rate.
|
After jelly consumption for 30 minutes
|
|
Concentration of interferon-gamma
Time Frame: Before and immediately after maximal oxygen consumption test
|
Study 3.2 determines concentration of interferon-gamma in serum in pg (picogram)/mL unit
|
Before and immediately after maximal oxygen consumption test
|
|
Concentration of tumor necrosis factor-alpha
Time Frame: Before and immediately after maximal oxygen consumption test
|
Study 3.2 determines concentration of tumor necrosis factor-alpha in serum in pg (picogram)/mL unit
|
Before and immediately after maximal oxygen consumption test
|
|
Concentration of interleukin-10
Time Frame: Before and immediately after maximal oxygen consumption test
|
Study 3.2 determines concentration of interleukin-10 in serum in pg (picogram)/mL unit
|
Before and immediately after maximal oxygen consumption test
|
|
Level of superoxide dismutase activity
Time Frame: Before and immediately after maximal oxygen consumption test
|
Study 3.2 determines level of superoxide dismutase activity in percentage (%) unit
|
Before and immediately after maximal oxygen consumption test
|
|
Concentration of malondialdehyde
Time Frame: Before and immediately after maximal oxygen consumption test
|
Study 3.2 determines concentration of malondialdehyde in micromolar (uM) unit
|
Before and immediately after maximal oxygen consumption test
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Piyapong Prasertsri, Ph.D., Burapha University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB1-047/2567
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rice Serum
-
Colorado State UniversityVirginia Polytechnic Institute and State University; University of North Carolina... and other collaboratorsCompletedDietary Rice Bran SupplementationUnited States, Nicaragua
-
Colorado State UniversityUniversity of the Sciences, Techniques and Technologies of BamakoCompletedDietary Rice Bran SupplementationUnited States, Mali
-
Tasso Inc.American Research LabsRecruiting
-
University Hospital, Basel, SwitzerlandMetromol SACompletedSerum FerritinSwitzerland
-
Utah State UniversityGlanbia NutritionalsActive, not recruiting
-
Shanghai 10th People's HospitalCompleted
-
University of DoualaCompleted
-
Tasso Inc.Completed
-
AmgenCompletedElevated Serum Lipoprotein(a)Hong Kong
-
Nutrition Institute, SloveniaNational Institute of Public Health, Slovenia; Slovenian Research Agency; Higher...Enrolling by invitationVitamin D Serum LevelsSlovenia
Clinical Trials on Study 1: Facial serum with alpha albutin
-
Victoria CollottaActive, not recruiting
-
Victoria CollottaActive, not recruiting
-
Benha UniversityCompletedAcne Vulgaris | Probiotic | Influence | Serum Leucine-Rich Alpha-2 Glycoprotein 1Egypt
-
rasha medhat abdul-hadyUnknownPlacenta AccretaEgypt
-
University of WashingtonNational Institute of Mental Health (NIMH); Mental Health America; TalkspaceCompleted
-
George Washington UniversityUniversity of Oklahoma; Bill and Melinda Gates Foundation; Department for International... and other collaboratorsActive, not recruiting
-
CSL BehringCompletedAcute-graft-versus-host DiseaseUnited States, Spain, Germany, Japan, South Korea, Australia, Italy, Turkey (Türkiye)
-
University of AlbertaCompletedPrimary Biliary CirrhosisCanada
-
Saglik Bilimleri UniversitesiRecruitingCovid-19 Positivity Confirmed With PCR Positivity in the Nasopharyngeal Swab | Symptomatic Covid -19 Positive Patients Who Require Hospitalization | Patients Who Did Not Vaccinate Against Covid-19 | Patients Among 20 to 90 Years of Age | Healthy Control Patients of the Same AgeTurkey
-
University Hospital of PatrasRecruitingDistal Radial Artery Access (dTRA) | Radial Artery AccessGreece